742391
Last Update Posted: 2015-03-06
Recruiting has ended
All Genders accepted | 18 Years + |
255 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.
Eligibility
Relevant conditions:
Actinic Keratoses
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov